Editor's choice articles 2006--2008.
Preissner
Klaus T
KT
D000818:Animals; D000925:Anticoagulants / Q000493:pharmacokinetics / Q000627:therapeutic use; D050197:Atherosclerosis / Q000097:blood / Q000188:drug therapy; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism; D055252:Cell-Derived Microparticles / Q000378:metabolism; D003141:Communicable Diseases / Q000097:blood / Q000188:drug therapy; D005343:Fibrinolytic Agents / Q000493:pharmacokinetics / Q000627:therapeutic use; D006487:Hemostasis / Q000187:drug effects / Q000235:genetics; D006801:Humans; D007249:Inflammation / Q000097:blood / Q000188:drug therapy; D009369:Neoplasms / Q000097:blood / Q000188:drug therapy; D010597:Pharmacogenetics; D018805:Sepsis / Q000097:blood / Q000188:drug therapy; D013927:Thrombosis / Q000097:blood / Q000188:drug therapy / Q000235:genetics
D000925:Anticoagulants; D005343:Fibrinolytic Agents